Key Takeaways
- VNB margin expanded to 27.4% as product mix, repricing and operating leverage offset a year of elevated mortality reserves; PAT fell 11% YoY on those same reserves.
- Protection delivered 24% APE growth, but the real story is the split: credit life surged 55% while individual protection remains throttled by a ~61% application-to-issue conversion rate the company is now systematically attacking.
- The Exide Life merger is the FY23 margin wildcard: standalone margins will keep rising, but management aims only to be margin-neutral on a consolidated basis next year while it invests to lift Exide's VNB margin from low single digits toward HDFC Life's level over 36–48 months.
- Non-par is being deliberately shortened: the new Sanchay FMP, already 15%+ of non-par mix, carries ~10-year tenures that make hedging easier and carry no internal cap on how large it can grow.
- What to watch next year: whether retail protection conversion moves from 61 toward 70–75, the pace of Exide Life's margin catch-up, and any regulatory enablers from IRDAI's newly constituted thematic groups.
Protection: The Two-Speed Engine
- Credit life is carrying the headline: new business premium grew 55% on the back of higher disbursements, and management expects that traction to continue. Repricing of several credit protect relationships during the pandemic has also improved the risk-return profile.
- Individual protection is a conversion problem, not a demand problem: out of every 100 applications, only ~61 policies are issued. The drop-off is driven by tighter sourcing guidelines, frontline confusion and attrition, back-and-forth between field and central ops, lack of a centralised medical database, and underwriting challenges in tier 2/3 locations.
- The fix is a three-part toolkit: MediEasy gives frontline salespersons a step-by-step guided journey; an assisted call center with chartered accountants helps non-salaried applicants document income; and MediTech enables proxy medical assessments for diabetes and heart conditions without physical exams. The stated target is to lift conversion to 70–75 per 100 applications.
- Underwriting automation is taking baby steps toward term: an ML-based engine is already live for savings products with a 0.001% error rate, substituting human underwriters for straight-through processing. The next phase will begin testing on term insurance, though management is cautious about the timeline.
- Mortality assumptions are still evolving: the 80 bps operating assumption change that hit both EV and VNB walks reflects portfolio experience as the book expands beyond the top 10 cities and the salaried segment into tier 2/3 and self-employed professionals. Management expects this evolution to continue.
Niraj Shah: "As you know, the protection journey is fairly recent in India right, over the last few years. We have now slowly started expanding from the top 10 cities and from the salaried segment into tier 2, tier 3 and to beyond the salaried into self-employed and professionals. So as that happens the mortality experience will evolve and that is something that will change mortality experience as you go forward..."
Exide Life: The Integration Math
- The merger is a margin-dilution-then-expansion story: Exide Life's VNB margin sits in low single digits, constrained by expense-of-management limits that prevented investment in agency growth, not by solvency. Management expects to scale those margins close to HDFC Life's level over 36–48 months, possibly less.
- Consolidated margin guidance for FY23 is flat, not up: while standalone HDFC Life margins will continue their upward trend, the combined entity is expected to end FY23 margin-neutral versus FY22. The company is explicitly prioritising investment in expanding the franchise over near-term margin accretion.
- The agency force is intact and ready to scale: Exide Life saw no major agent loss through the process; Q4 recruitment was on target and activation was in line with the industry. Post-merger, the 40,000-strong FC base will be further activated, and the agency model will expand geographically beyond Exide's traditional strongholds.
- Branch rationalisation is designed but not yet executed: a backend exercise to identify overlapping branches is complete, but no rationalisation has been implemented. The entity continues to run as a separate subsidiary until NCLT approval, expected in the second half of FY23.
- The HDFC Bank merger adds a second integration vector: post the HDFC Ltd–HDFC Bank merger, HDFC Life becomes a subsidiary of HDFC Bank. Brainstorming across group CEOs has already begun, with the stated intention to leverage the combined group's power for customer solutions and cross-sell.
Suresh Badami: "They have been constrained on their growth because of their capital and many other thresholds which they have not been able to invest in that business. I think, a lot of those hindrances will go away once they become part of the HDFC Group."
Non-Par & the Duration Pivot
- The Sanchay FMP is reshaping the non-par book: launched in the second half of FY22, it now contributes more than 15% of the non-par savings mix. It is a ~10-year product, largely single premium (1:10) or limited premium (5:10), which deliberately shortens the overall policy duration on non-par.
- There is no internal cap on how large FMP can grow: management stated the product can hypothetically go beyond 40% or 50% of non-par mix if demand exists. The constraint is not appetite but the attractiveness of the product relative to competing instruments.
- The hedging logic is straightforward: shorter-tenure, single-premium products are easier to hedge than long-duration non-par. The company uses a multi-pronged hedging approach combining internal capacity and external instruments, and believes it has no relative disadvantage versus peers on instruments like FRAs.
- Demand holds even as rates rise: management argues the key is relative attractiveness versus other fixed-income instruments, not absolute rates. The 10-year term differentiates it from short-term fixed deposits, and the tax advantage adds further appeal.
Niraj Shah: "The key really is not absolute rates, it is a relative proposition to what other instruments are available... Relative to what is available in the market, it continues to be attractive whichever way the interest rates have gone."
Margins: The Building Blocks
- The 27.4% VNB margin was built on four levers: product mix shift toward higher-margin non-par (32% to 35% of mix) and annuities, repricing of a large part of the book over the prior 12–18 months, lower group business composition versus the same quarter last year, and operating leverage from scale.
- The 80 bps operating assumption drag is a recurring feature, not a one-off: it reflects updated mortality assumptions at the beginning of the period, driven by portfolio experience as the protection book diversifies into tier 2/3 and non-salaried segments. Management expects this evolution to continue and be reflected going forward.
- Positive operating variance added ~₹150 Crores to EV: two-thirds came from persistency improvements (13th month up to 92% from 90%, 61st month up to 58% from 53%) and one-third from expense variance.
- Economic variance was flat for the year: positive equity movements cancelled out negative interest rate movements, where a higher increase at the shorter end versus the longer end created the negative variance on the interest rate side.
- The medium-term aspiration is ~30% VNB margin on a merged basis: this assumes no drop in market share (holding the #3 position among listed players including LIC) and does not factor in potential regulatory enablers. Beyond that, the story becomes a compounding one of ~20% YoY VNB growth.
Vibha Padalkar: "It should be possible. All things being equal on regulations, it should be possible and that is what we will be working towards. It will kind of stabilize around that, and this is, of course, with the caveat that we do not drop market share."
Solvency, Capital & Reinsurance
- Solvency dropped to 176% from 190% entirely because of the ₹726 Crore cash payout for the Exide Life acquisition, which impacted solvency by 13 percentage points. Excluding that, solvency would have been 189%.
- The target range is 180–190%: the distance from 176% is not large, so the capital raise needed is not significant. The board has approved a ₹350 Crore sub-debt raise, additional to the ₹600 Crore already raised earlier, and management will not rule out a combination of equity or debt over time.
- Capital will not constrain growth: management was explicit that when there is an opportunity to grow and create value, capital will not be a constraint. The capacity to write non-par is only expected to increase given the back-book the business has built.
- Reinsurers remain on high alert: the stance is not expected to change immediately; it depends on the trajectory of wave 4. Management's personal sense is that the high-alert situation should ease "over a period of time" but is "still someway away."
- Lower reinsurance on retail protection does not hurt margins: the company captures the risk charge itself, and the delta between reinsurer pricing and its own risk charge assessment is not large, especially after both reinsurers and HDFC Life increased prices.
Niraj Shah: "For us the bottom line really is that when there is an opportunity to grow and create value, we will not let capital be a constraint."
Distribution & Channel Mix
- Proprietary distribution has grown from 23% to 33% of mix over five years: the agency channel grew 26% and added over 40,000 agents. This shift reduces dependence on bancassurance partners and strengthens control over product mix.
- The HDFC Bank merger creates a direct alignment opportunity: post-merger, HDFC Life becomes a subsidiary of HDFC Bank, and cross-sell brainstorming across group CEOs has already begun. The stated intention is to leverage the group's power to deliver solutions to customers.
- Annuity distribution is deepening: the Systematic Retirement Plan, a regular-pay deferred annuity product, was rolled out during the year. Annuities now contribute over a fifth of new business premiums and have almost doubled in three years, growing at 24% versus industry growth of 3%.
Vibha Padalkar: "This is just the beginning Suresh. We are of course brainstorming with CEOs of respective companies that is already more than started happening so I think certainly the intention is very clear that how do we leverage the power of the group to be able to give solutions to the customer."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Consolidated VNB margin | Margin-neutral versus FY22 on a merged basis with Exide Life | FY23 |
| Standalone VNB margin | Continue upward trajectory | Ongoing |
| Exide Life VNB margin | Scale from low single digits to close to HDFC Life levels | 36–48 months post-merger |
| Retail protection conversion | Improve from ~61 to 70–75 policies issued per 100 applications | No date (process underway) |
| Retail protection growth | At least comfortable double-digit growth | FY23 |
| Solvency target | 180–190% range | Ongoing |
| Exide Life merger completion | NCLT approval and legal merger | H2 FY23 |
| Medium-term VNB margin (merged) | Move closer to 30%, assuming no market share loss | Medium term |
| Individual protection growth | Grow using data analytics, customer insights and calibrated risk retention | FY23 |
Key Metrics
| Metric | Q4 FY22 |
|---|---|
| Value of New Business (VNB) | ₹2,675 cr, 22% higher than FY21 |
| New business margin (VNB margin) | 27.4%, vs 26.1% for FY21 |
| Embedded Value | ₹30,048 cr as on March 31, 2022, almost doubled in last 4 years |
| Operating return on EV (excl. excess mortality reserve) | 19.0%, vs 18.5% for FY21 |
| Operating return on EV (incl. excess mortality reserve) | 16.6% |
| Profit after Tax (PAT) | ₹1,208 cr, decline of 11% vs FY21; Q4 PAT grew 12% YoY |
| Solvency ratio | 176% as on March 31, 2022; 189% excluding ₹726 cr Exide Life cash payout |
| Individual APE product mix | Non-par savings 33%, participating 30%, ULIPs 26%, individual protection 6%, annuity 5% |
| Overall protection APE growth | 24% YoY; new business premium growth 47% YoY |
| Credit life new business premium growth | 55% YoY |
| Annuity business growth | 24% YoY vs industry growth of 3% |
| Renewal premium growth | 18% YoY |
| 13th month persistency | 92%, up from 90% in FY21 |
| 61st month persistency | 58%, up from 53% in FY21 |
| Lives covered | 5.4 cr, increase of 36% over FY21 |
| Agency channel growth | 26% YoY; added more than 40,000 agents in FY22 |
| HDFC Pension AUM | ₹28,414 cr, uptick of 73% vs previous year; market share of 37% |
| Exide Life Embedded Value | ₹2,910 cr as on March 31, 2022 |
| Exide Life individual WRP growth | 22% in FY22, vs industry growth of 16% |
| Dividend per share | ₹1.70, payout of ~30% of PAT |
| Board-approved sub-debt raise | ₹350 cr, expected to increase solvency by ~600 bps |
| Covid reserves carried into FY23 | ₹55 cr |
| Gross claims in FY22 | ₹5,804 cr; net claims ₹4,328 cr |
| HDFC International Life and Re GWP | \$15.64 mn, 18% YoY growth |
| FRA exposure | ₹18,000–19,000 cr at end of FY2022, vs ₹13,700 cr at end of FY2021 |
| Sanchay FMP contribution | More than 15% of non-par savings mix since launch |
| Retail protection application conversion rate | ~61 out of every 100 currently; pre-COVID was ~75 out of 100 |
| Exide Life VNB margin post-overrun | Low single digit; expected to approach HDFC Life margins over 36–48 months |
| Exide Life agency force | ~40,000 financial consultants |
| HDFC Ltd stake in HDFC Life | 47.8% as on March 31, 2022 |
| 2-year CAGR (HDFC Life) | 17% vs industry 9% |
| Standalone Q4 FY22 2-year CAGR | 23% for HDFC Life; 19% for total industry |
| Two-year CAGR of par | ~44% |
| Operating variance breakup | ~two-thirds positive persistency variance, ~one-third positive expense variance |
| Economic variance | Fairly flat for FY22; equity and interest rate movements cancelled each other out |
| Non-par mix expansion in Q4 | From 32% to 35% |
| Regulatory solvency requirement | 150%; company uses 170% for EV purposes |
| Advertisement spends in HDFC Bank channel | ~₹800 cr in nine months FY2022 |
| Equity sensitivity | 1.4% negative impact on EV for a 10% instantaneous fall in equity values |
| Exide Life solvency | 217% |
| Tier-2 debt raised earlier | ₹600 cr; further raise underway |